Lyme Disease
Research Study

Researchers at the National Institute of Allergy and Infectious Diseases are conducting a study to develop a population of patients with Lyme disease who will serve as the basis for research in multiple aspects of this infection. Join our study today!

Fast Facts

recent diagnosis of lyme disease (or suspect have the Lyme disease rash)

Must have medical provider for non-protocol-related care

willing to travel to the NIH clinical center in bethesda, MD

Study Background

Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) are recruiting participants with a recent Lyme disease diagnosis to advance scientific knowledge.

The Lyme disease rash is usually round or oval and gradually expands. It may be all red or have a bull’s-eye appearance. If untreated, the infection may spread to other parts of the body and cause other problems, including paralysis of the face (called facial palsy), severe headache, stiff neck, heart palpitations or changes in heartbeat, and joint pain and swelling.

If you have Lyme disease, you may be eligible to participate in the research study. The study offers evaluation, therapy, and follow-up to patients with Lyme disease according to accepted medical standards.

Further research today and join our study!

Additional Information

The purpose of this clinical research study is to evaluate, treat, and observe patients with Lyme disease over the long term. We want to learn more about how Lyme disease appears in different people so that we have specific benchmarks to refer to during future research.

You may qualify for this study if you meet the following criteria.

Key Criteria:

  • Recent diagnosis of Lyme disease (or suspect have the Lyme disease rash)
  • Must have a medical provider for non-protocol-related care
  • Willing to travel to the NIH Clinical Center in Bethesda, MD

Once enrolled, this study involves:

  • Undergoing a history and physical examination
  • Completing a laboratory and diagnostic evaluation
    • Routine blood and urine studies
    • X-rays or other tests as clinically indicated
    • Tests of other body fluids or tissues as clinically indicated
  • If clinically indicated, standard treatment may be offered
  • Attending follow-up visits at the end of therapy, 3, 6, and 12 months after
  • Attending long-term follow-up visits every 6-12 months for up to 10 years
    • More or less frequent follow-up visits may be indicated as clinically appropriate

There is no compensation for this study. Travel assistance for follow-up visits may be available for individuals living over 50 miles from the NIH Clinical Center. Per NIAID policy, travel assistance for the initial visit is not covered.

There is no cost for you to participate in this study.